Molecular Pathology of Rare Diseases
MolPath-RD
![Foto de Molecular Pathology of Rare Diseases](/img/grupo.png)
![Foto de University of Edinburgh](/img/noimage_org.png)
University of Edinburgh
Edimburgo, Reino UnidoPublications in collaboration with researchers from University of Edinburgh (4)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2015
-
Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF
Journal of the American Heart Association, Vol. 5, Núm. 3
2012
-
Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits
Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4406-4418